ID

16730

Beschrijving

Sponsor: OSI Pharmaceuticals Information provided by (Responsible Party): Astellas Pharma Inc (OSI Pharmaceuticals) A multicenter, randomized, double-blind, placebo-controlled, phase 3 study of single-agent Tarceva® (erlotinib) following complete tumor resection with or without adjuvant chemotherapy in patients with stage IB-IIIA non-small cell lung carcinoma who have EGFR-positive tumors. See https://clinicaltrials.gov/ct2/show/NCT00373425 Part of study: Concomitant Medications

Link

https://clinicaltrials.gov/ct2/show/NCT00373425

Trefwoorden

Versies (2)
  1. 02-08-16 02-08-16 -
  2. 03-08-16 03-08-16 - Julian Varghese
Geüploaded op

3 augustus 2016

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

  • Nieuwste
  • Oudste
  • Populair
  • Nieuwste
    • Nieuwste
    • Oudste
    • Populair

Geen commentaren

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Concomitant Medications, Tarceva in NSCLC patients who have EGFR-positive tumors DRKS00001485 NCT00373425

Engels

Concomitant Medications, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425

1 Formulieren  
Concomitant Medications
Beschrijving

Concomitant Medications

Concomitant Medication
Beschrijving

Concomitant Medication

Datatype

boolean

Alias
UMLS CUI [1]
C2347852
Medications
Beschrijving

Medications

Medication (Use generic name when possible)
Beschrijving

Concomitant Medication

Datatype

text

Alias
UMLS CUI [1]
C2347852
Prophylaxis
Beschrijving

Indication Prophylaxis

Datatype

boolean

Alias
UMLS CUI [1,1]
C2826696
UMLS CUI [1,2]
C0199176
Indication
Beschrijving

Indication

Datatype

text

Alias
UMLS CUI [1]
C2826696
Date started: Prestudy
Beschrijving

Concomitant Medication Start Date

Datatype

boolean

Alias
UMLS CUI [1]
C2826734
Date started
Beschrijving

Concomitant Medication Start Date

Datatype

date

Alias
UMLS CUI [1]
C2826734
Date stopped: Post treatment
Beschrijving

Concomitant Medication End Date

Datatype

boolean

Alias
UMLS CUI [1]
C2826744
Date stopped
Beschrijving

Concomitant Medication End Date

Datatype

date

Alias
UMLS CUI [1]
C2826744
Terug naar het begin van de pagina

Similar models

Concomitant Medications, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Concomitant Medications
Concomitant Medication
Item
Concomitant Medication
boolean
C2347852 (UMLS CUI [1])
Item Group
Medications
Concomitant Medication
Item
Medication (Use generic name when possible)
text
C2347852 (UMLS CUI [1])
Indication Prophylaxis
Item
Prophylaxis
boolean
C2826696 (UMLS CUI [1,1])
C0199176 (UMLS CUI [1,2])
Indication
Item
Indication
text
C2826696 (UMLS CUI [1])
Concomitant Medication Start Date
Item
Date started: Prestudy
boolean
C2826734 (UMLS CUI [1])
Concomitant Medication Start Date
Item
Date started
date
C2826734 (UMLS CUI [1])
Concomitant Medication End Date
Item
Date stopped: Post treatment
boolean
C2826744 (UMLS CUI [1])
Concomitant Medication End Date
Item
Date stopped
date
C2826744 (UMLS CUI [1])
Terug naar het begin van de pagina 

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial